Sternal Osteomyelitis

Comprehensive Clinical Guide: Sternal Osteomyelitis

Sternal Osteomyelitis (SOM) represents one of the most challenging and high-stakes clinical scenarios in cardiothoracic surgery and infectious disease management. Often secondary to median sternotomy—the standard approach for open-heart surgery—this condition involves the infection of the sternal bone and the surrounding mediastinal tissues. Because the sternum is a critical structural component of the thoracic cage and sits directly anterior to the heart and great vessels, SOM is not merely a bone infection; it is a potentially life-threatening systemic crisis.

This guide serves as an authoritative resource for clinicians, surgeons, and medical professionals to understand the pathophysiology, diagnostic pathways, and management strategies for this complex orthopedic-infectious pathology.

1. Clinical Definition and Etiology

Definition

Sternal Osteomyelitis is defined as the inflammatory process of the sternum resulting from bacterial or fungal invasion, characterized by bone marrow edema, osteolysis, and, in advanced stages, the formation of sequestra (necrotic bone fragments) and involucrum (new reactive bone).

Etiology and Risk Factors

The vast majority of SOM cases are post-surgical, specifically following cardiac procedures. However, hematogenous spread and direct trauma also contribute to its incidence.

2. Pathophysiology and Mechanisms

The pathogenesis of SOM is typically multifactorial. Following a sternotomy, the sternum is vulnerable due to compromised vascularity. When pathogens (most commonly Staphylococcus aureus or Staphylococcus epidermidis) colonize the surgical site, they form biofilms on the stainless-steel sternal wires.

The Biofilm Mechanism

Biofilms are highly resistant to host immune defenses and systemic antibiotics. The extracellular polymeric substance (EPS) matrix produced by staphylococci acts as a physical barrier, slowing the diffusion of antibiotics and shielding bacteria from phagocytosis. Once the biofilm is established, the infection progresses from the superficial soft tissues into the marrow space of the sternum, leading to ischemia and necrosis of the bone trabeculae.

Inflammatory Cascade

1. Invasion: Bacteria enter via surgical trauma or hematogenous seeding.
2. Adherence: Bacteria adhere to the bone matrix or hardware surfaces.
3. Proliferation: Colony formation and biofilm maturation occur.
4. Bone Resorption: Osteoclasts are activated by inflammatory cytokines (IL-1, IL-6, TNF-alpha), leading to bone destruction.
5. Sequestration: Devitalized bone segments are isolated from the blood supply, becoming a persistent nidus for infection.

3. Clinical Staging and Classification

The Oak-Surgical Classification (modified) is frequently utilized to gauge the severity of sternal wounds and associated osteomyelitis.

• Stage I: Superficial infection (skin and subcutaneous tissue only).
• Stage II: Deep infection involving the sternum without mediastinal involvement.
• Stage III: Deep sternal wound infection (DSWI) with mediastinitis (involvement of the retrosternal space).
• Stage IV: Chronic SOM with fistula formation or exposed necrotic bone.

4. Clinical Presentation and Diagnostic Evaluation

Standard Presentation

Patients typically present with:
* Persistent pain: Localized tenderness at the sternal site.
* Wound drainage: Purulent discharge or serosanguinous fluid from the incision.
* Sternal Instability: A "clicking" sensation upon movement or coughing (sternal dehiscence).
* Systemic Symptoms: Low-grade fever, malaise, and leukocytosis.

Key Diagnostic Tests

A multi-modal approach is required for definitive diagnosis.

5. Differential Diagnosis

Clinicians must distinguish SOM from:
1. Non-infectious Sternotomy Dehiscence: Mechanical failure without active infection.
2. Post-pericardiotomy Syndrome: An inflammatory response to surgery that can mimic systemic infection.
3. Malignancy: Primary or metastatic bone tumors of the sternum.
4. Radiation Osteonecrosis: In patients with a history of chest wall radiation.

6. Risks, Side Effects, and Management

Contraindications to Conservative Management

Conservative management (antibiotics alone) is generally contraindicated in patients with:
* Large sequestra.
* Sternal instability.
* Persistent purulent drainage.
* Involvement of the great vessels.

Surgical Management

The cornerstone of treatment is surgical debridement. This involves:
1. Radical Debridement: Removal of all infected, necrotic bone and infected hardware (wires/plates).
2. Tissue Coverage: Utilization of vascularized muscle flaps (e.g., pectoralis major, rectus abdominis) to fill the dead space and improve local blood supply to the area.
3. Negative Pressure Wound Therapy (NPWT): Used as a bridge to definitive closure to manage exudate and promote granulation.

7. Prognosis and Long-term Outlook

The prognosis for SOM depends on the timing of intervention. Early detection and aggressive debridement typically result in a 75-90% cure rate. However, patients with underlying comorbidities (diabetes, chronic steroid use) face higher rates of recurrence and long-term morbidity, including chronic chest wall pain and the potential for secondary mediastinitis.

8. Frequently Asked Questions (FAQ)

Q1: Can Sternal Osteomyelitis occur without prior heart surgery?
Yes. While rare, it can occur via hematogenous spread from distant sites (e.g., infected IV lines, dental infections) or through direct trauma.

Q2: Why is the sternum so susceptible to infection?
The sternum is a flat bone with a thin cortex and limited vascular supply, especially after being split and retracted during surgery, making it highly susceptible to ischemic necrosis.

Q3: What is the most common pathogen?
Staphylococcus aureus is the most common, followed by coagulase-negative staphylococci and gram-negative bacilli.

Q4: How long should antibiotic therapy last?
Treatment typically requires 6–12 weeks of targeted intravenous antibiotics, depending on the severity and whether infected hardware has been removed.

Q5: Is a CT scan better than an MRI for diagnosis?
CT is generally preferred for its ability to visualize bone architecture and hardware complications, while MRI is superior for early detection of bone marrow edema.

Q6: What is a "sternal flap"?
It is a surgical procedure where healthy muscle (usually the pectoralis major) is detached from its origin and rotated to cover the debrided sternal defect, providing blood supply to help the bone heal.

Q7: Can I return to normal activity after SOM?
Yes, but sternal precautions (lifting limitations) are usually required for 3–6 months post-repair to ensure the sternum heals properly.

Q8: What are the signs of a failing sternal wound?
Increasing pain, redness, warmth, foul-smelling drainage, and a clicking sensation in the chest are major warning signs.

Q9: Does smoking affect the healing of Sternal Osteomyelitis?
Yes. Smoking causes vasoconstriction and systemic hypoxia, significantly delaying bone healing and increasing the risk of wound recurrence.

Q10: Is hardware removal mandatory?
If the hardware is loose or associated with a biofilm, it must be removed. In some cases, if the bone is stable and infection is superficial, hardware may be retained, but this is a clinical judgment.

9. Conclusion

Sternal Osteomyelitis is a formidable diagnosis that requires an aggressive, multi-disciplinary approach. By integrating rapid diagnostic imaging, radical surgical debridement, and targeted antimicrobial therapy, the clinical team can mitigate the risks of life-threatening mediastinitis and restore structural integrity to the thoracic cage. Ongoing surveillance is mandatory for any patient who has undergone a median sternotomy, as early intervention remains the most significant predictor of a positive clinical outcome.

Disclaimer: This guide is for educational purposes for healthcare professionals and does not replace institutional protocols or direct clinical judgment.